GRIFOLS | GRF - Operating Profit



GRIFOLS reported EUR349.54M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Alcon AG USD 247M 221M Jun/2025
Almirall EUR 43.02M 8.82M Jun/2025
Amadeus IT EUR 494.2M 32.4M Jun/2025
Amarin USD -16755000 35.77M Mar/2025
argenx SE USD 203.84M 64.9M Jun/2025
AstraZeneca USD 3.51B 166M Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Cie Automotive EUR 250.28M 37.83M Dec/2024
Demant DKK 1.87B 471M Jun/2025
Ence Energia y Celulosa EUR -4600000 30.7M Jun/2025
Essilor EUR 2B 1.22B Jun/2025
Ferrovial EUR 431M 2.13B Jun/2025
Fresenius EUR 560M 127M Jun/2025
Fresenius Medical Care EUR 431M 100M Jun/2025
Galapagos EUR -57027000 101.68M Jun/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 2.02B 193M Jun/2025
GRIFOLS EUR 349.54M 80.68M Jun/2025
Hikma Pharmaceutical USD 282M 45M Dec/2024
Inditex EUR 1.64B 279.51M Apr/2025
Merck EUR 1.03B 24M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Philips EUR 488M 334M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025
Smith & Nephew USD 440M 111M Jun/2025
UCB EUR 1B 678M Dec/2024
Viscofan EUR 54.99M 8.11M Jun/2025